Fiche publication
Date publication
décembre 2016
Journal
Planta medica
Auteurs
Membres identifiés du Cancéropôle Est :
Pr BEDUNEAU Arnaud
Tous les auteurs :
Dubray O, Moulari B, Chrétien C, Pellequer Y, Lamprecht A, Mitaine-Offer AC, Lacaille-Dubois MA, Béduneau A
Lien Pubmed
Résumé
The oral of drugs is often limited due to the presence of the P-glycoprotein, an efflux pump strongly expressed on the luminal side of the intestinal barrier. In an attempt to circumvent drug efflux, strategies consisting in the coadministration of drugs with surface-active agents have been found to be promising. In this context, the role of saponins on the intestinal permeability of a P-glycoprotein substrate was investigated. The P-glycoprotein inhibition activity of three triterpenoid saponins extracted from several plants of the Caryophyllaceae family was evaluated using an intestinal barrier model comprised of Caco-2 cell lines. The results showed a strong effect of two saponins on P-glycoprotein-mediated transport. At a concentration of 15 µM, the efflux ratio was close to 1 for both saponins, thus suggesting a total inhibition of the efflux pump in contrast to verapamil HCl, a conventional P-glycoprotein inhibitor. In addition, measurements of the transepithelial electrical resistance revealed that the integrity of the monolayers was not altered at such concentrations, thereby reducing potential adverse effects. The presence of acetylated sugars in the saponin structure could possibly facilitate interactions with the efflux pump by an ATP-dependent mechanism or by fluidization of cell membranes.
Mots clés
ATP Binding Cassette Transporter, Subfamily B, Member 1, antagonists & inhibitors, Caco-2 Cells, Caryophyllaceae, chemistry, Humans, Intestinal Mucosa, metabolism, Permeability, drug effects, Saponins, isolation & purification, Triterpenes, isolation & purification
Référence
Planta Med. 2016 12;82(18):1553-1557
